Physician profile
Jigar Patel
NPI 1760678049
$9,637.83
in general payments reported to CMS, 2019-2025
35 companies · $3,457 in 2025
The $3,457 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $788 · 2021: $1,792 · 2022: $1,195 · 2023: $968 · 2024: $665 · 2025: $3,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,048 · Travel and Lodging: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,048.27 |
| Travel and Lodging | $1,042.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,582.06 | 2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $941.57 | 2021-2025 | Lifevest |
| Abiomed | $828.71 | 2022-2025 | Impella |
| Medtronic, INC. | $775.18 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Hawkone |
| Medtronic Vascular, INC. | $656.31 | 2019-2020 | |
| Philips North America LLC | $558.62 | 2022 | |
| Boston Scientific Corporation | $458.65 | 2020-2025 | General - Therapies, Rotapro, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $450.87 | 2019-2025 | |
| Heartflow, INC. | $392.07 | 2023-2025 | Ffrct |
| Amgen INC. | $349.34 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $262.62 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $255.48 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $228.26 | 2021 | |
| Edwards Lifesciences Corporation | $189.45 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $175.57 | 2020-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $170.54 | 2021 | |
| Biosense Webster, INC. | $156.35 | 2021 | |
| Kestra Medical Technology Services, INC. | $146.22 | 2024-2025 | Assure Wcd |
| Stryker Corporation | $136.57 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Radius Health, INC. | $124.99 | 2019 | |
| Tactile Systems Technology INC | $114.76 | 2021 | |
| Pfizer INC. | $112.13 | 2022-2025 | |
| Lilly USA, LLC | $93.46 | 2019 | |
| Cardiva Medical, INC. | $91.79 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $77.85 | 2025 | |
| Janssen Pharmaceuticals, INC | $68.67 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $47.67 | 2019-2020 | |
| Zoll Respicardia, INC. | $46.49 | 2023-2024 | Remede System |
| Novo Nordisk INC | $37.07 | 2022 | |
| Merck Sharp & Dohme LLC | $30.67 | 2022 | |
| Conmed Corporation | $27.35 | 2023 | |
| W. L. Gore & Associates, INC. | $15.03 | 2019 | |
| Microvention, INC. | $14.56 | 2023 | Web Aneurysm Embolization System, Balloon Catheter |
| Kowa Pharmaceuticals America, INC. | $12.47 | 2020 | |
| Cardiovascular Systems INC. | $8.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jigar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.